Selected research
Industry Research
Veterinary Follicle Stimulating Hormones (FSH) Industry Research Report 2026
Market perspective
The global Veterinary Follicle Stimulating Hormones (FSH) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Veterinary Follicle Stimulating Hormones (FSH) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Veterinary Follicle Stimulating Hormones (FSH) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Veterinary Follicle Stimulating Hormones (FSH) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Veterinary Follicle Stimulating Hormones (FSH) include Vetoquinol, Trophogen, Inc, SUMU, Ningbo Second Hormone Factory, MSD, Laboratorios HIPRA, S.A. and Calier, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Veterinary Follicle Stimulating Hormones (FSH) market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Veterinary Follicle Stimulating Hormones (FSH) Market by Company
Vetoquinol
Trophogen, Inc
SUMU
Ningbo Second Hormone Factory
MSD
Laboratorios HIPRA, S.A.
Calier
Veterinary Follicle Stimulating Hormones (FSH) Segment by Type
Serum Gonadotrophin and Chorionic Gonadotrophin
Chorionic Gonadotrophin
Folltropin
Others
Veterinary Follicle Stimulating Hormones (FSH) Segment by Application
Horse
Bovine
Sheep
Others
Veterinary Follicle Stimulating Hormones (FSH) Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Follicle Stimulating Hormones (FSH) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary Follicle Stimulating Hormones (FSH) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Follicle Stimulating Hormones (FSH).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Veterinary Follicle Stimulating Hormones (FSH) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Veterinary Follicle Stimulating Hormones (FSH) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Veterinary Follicle Stimulating Hormones (FSH) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Serum Gonadotrophin and Chorionic Gonadotrophin
- Chorionic Gonadotrophin
- Folltropin
- Others
Applications
- Horse
- Bovine
- Sheep
- Others
Companies covered
- Vetoquinol
- Trophogen, Inc
- SUMU
- Ningbo Second Hormone Factory
- MSD
- Laboratorios HIPRA, S.A.
- Calier
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Veterinary Follicle Stimulating Hormones (FSH) Market Size (2021-2032)
- 2.2.2 Global Veterinary Follicle Stimulating Hormones (FSH) Sales (2021-2032)
- 2.2.3 Global Veterinary Follicle Stimulating Hormones (FSH) Market Average Price (2021-2032)
- 2.3 Veterinary Follicle Stimulating Hormones (FSH) by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Serum Gonadotrophin and Chorionic Gonadotrophin
- 2.3.3 Chorionic Gonadotrophin
- 2.3.4 Folltropin
- 2.3.5 Others
- 2.4 Veterinary Follicle Stimulating Hormones (FSH) by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Horse
- 2.4.3 Bovine
- 2.4.4 Sheep
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Veterinary Follicle Stimulating Hormones (FSH) Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Veterinary Follicle Stimulating Hormones (FSH) Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue of Manufacturers (2021-2026)
- 3.4 Global Veterinary Follicle Stimulating Hormones (FSH) Average Price by Manufacturers (2021-2026)
- 3.5 Global Veterinary Follicle Stimulating Hormones (FSH) Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Veterinary Follicle Stimulating Hormones (FSH), Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Veterinary Follicle Stimulating Hormones (FSH), Product Type & Application
- 3.8 Global Manufacturers of Veterinary Follicle Stimulating Hormones (FSH), Established Date
- 3.9 Global Veterinary Follicle Stimulating Hormones (FSH) Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Vetoquinol
- 4.1.1 Vetoquinol Company Information
- 4.1.2 Vetoquinol Business Overview
- 4.1.3 Vetoquinol Veterinary Follicle Stimulating Hormones (FSH) Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Vetoquinol Veterinary Follicle Stimulating Hormones (FSH) Product Portfolio
- 4.1.5 Vetoquinol Recent Developments
- 4.2 Trophogen, Inc
- 4.2.1 Trophogen, Inc Company Information
- 4.2.2 Trophogen, Inc Business Overview
- 4.2.3 Trophogen, Inc Veterinary Follicle Stimulating Hormones (FSH) Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Trophogen, Inc Veterinary Follicle Stimulating Hormones (FSH) Product Portfolio
- 4.2.5 Trophogen, Inc Recent Developments
- 4.3 SUMU
- 4.3.1 SUMU Company Information
- 4.3.2 SUMU Business Overview
- 4.3.3 SUMU Veterinary Follicle Stimulating Hormones (FSH) Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 SUMU Veterinary Follicle Stimulating Hormones (FSH) Product Portfolio
- 4.3.5 SUMU Recent Developments
- 4.4 Ningbo Second Hormone Factory
- 4.4.1 Ningbo Second Hormone Factory Company Information
- 4.4.2 Ningbo Second Hormone Factory Business Overview
- 4.4.3 Ningbo Second Hormone Factory Veterinary Follicle Stimulating Hormones (FSH) Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Ningbo Second Hormone Factory Veterinary Follicle Stimulating Hormones (FSH) Product Portfolio
- 4.4.5 Ningbo Second Hormone Factory Recent Developments
- 4.5 MSD
- 4.5.1 MSD Company Information
- 4.5.2 MSD Business Overview
- 4.5.3 MSD Veterinary Follicle Stimulating Hormones (FSH) Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 MSD Veterinary Follicle Stimulating Hormones (FSH) Product Portfolio
- 4.5.5 MSD Recent Developments
- 4.6 Laboratorios HIPRA, S.A.
- 4.6.1 Laboratorios HIPRA, S.A. Company Information
- 4.6.2 Laboratorios HIPRA, S.A. Business Overview
- 4.6.3 Laboratorios HIPRA, S.A. Veterinary Follicle Stimulating Hormones (FSH) Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Laboratorios HIPRA, S.A. Veterinary Follicle Stimulating Hormones (FSH) Product Portfolio
- 4.6.5 Laboratorios HIPRA, S.A. Recent Developments
- 4.7 Calier
- 4.7.1 Calier Company Information
- 4.7.2 Calier Business Overview
- 4.7.3 Calier Veterinary Follicle Stimulating Hormones (FSH) Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Calier Veterinary Follicle Stimulating Hormones (FSH) Product Portfolio
- 4.7.5 Calier Recent Developments
5 Global Veterinary Follicle Stimulating Hormones (FSH) Market Scenario by Region
- 5.1 Global Veterinary Follicle Stimulating Hormones (FSH) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Region: 2021-2032
- 5.2.1 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Region: 2021-2026
- 5.2.2 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Region: 2027-2032
- 5.3 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Region: 2021-2032
- 5.3.1 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Region: 2021-2026
- 5.3.2 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Region: 2027-2032
- 5.4 North America Veterinary Follicle Stimulating Hormones (FSH) Market Facts & Figures by Country
- 5.4.1 North America Veterinary Follicle Stimulating Hormones (FSH) Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Veterinary Follicle Stimulating Hormones (FSH) Sales by Country (2021-2032)
- 5.4.3 North America Veterinary Follicle Stimulating Hormones (FSH) Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Veterinary Follicle Stimulating Hormones (FSH) Market Facts & Figures by Country
- 5.5.1 Europe Veterinary Follicle Stimulating Hormones (FSH) Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Veterinary Follicle Stimulating Hormones (FSH) Sales by Country (2021-2032)
- 5.5.3 Europe Veterinary Follicle Stimulating Hormones (FSH) Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Veterinary Follicle Stimulating Hormones (FSH) Market Facts & Figures by Country
- 5.6.1 Asia Pacific Veterinary Follicle Stimulating Hormones (FSH) Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Veterinary Follicle Stimulating Hormones (FSH) Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Veterinary Follicle Stimulating Hormones (FSH) Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Veterinary Follicle Stimulating Hormones (FSH) Market Facts & Figures by Country
- 5.7.1 South America Veterinary Follicle Stimulating Hormones (FSH) Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Veterinary Follicle Stimulating Hormones (FSH) Sales by Country (2021-2032)
- 5.7.3 South America Veterinary Follicle Stimulating Hormones (FSH) Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Veterinary Follicle Stimulating Hormones (FSH) Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Veterinary Follicle Stimulating Hormones (FSH) Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Veterinary Follicle Stimulating Hormones (FSH) Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Veterinary Follicle Stimulating Hormones (FSH) Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Type (2021-2032)
- 6.1.1 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Market Share by Type (2021-2032)
- 6.2 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Type (2021-2032)
- 6.2.1 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue Market Share by Type (2021-2032)
- 6.3 Global Veterinary Follicle Stimulating Hormones (FSH) Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Application (2021-2032)
- 7.1.1 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Market Share by Application (2021-2032)
- 7.2 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Application (2021-2032)
- 7.2.1 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue Market Share by Application (2021-2032)
- 7.3 Global Veterinary Follicle Stimulating Hormones (FSH) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Veterinary Follicle Stimulating Hormones (FSH) Value Chain Analysis
- 8.1.1 Veterinary Follicle Stimulating Hormones (FSH) Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Veterinary Follicle Stimulating Hormones (FSH) Production Mode & Process
- 8.2 Veterinary Follicle Stimulating Hormones (FSH) Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Veterinary Follicle Stimulating Hormones (FSH) Distributors
- 8.2.3 Veterinary Follicle Stimulating Hormones (FSH) Customers
9 Global Veterinary Follicle Stimulating Hormones (FSH) Analyzing Market Dynamics
- 9.1 Veterinary Follicle Stimulating Hormones (FSH) Industry Trends
- 9.2 Veterinary Follicle Stimulating Hormones (FSH) Industry Drivers
- 9.3 Veterinary Follicle Stimulating Hormones (FSH) Industry Opportunities and Challenges
- 9.4 Veterinary Follicle Stimulating Hormones (FSH) Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst